Breakthrough Candida albicans bloodstream infection associated with in vivo development of pan-azole resistance related to ERG3 gene deletion

Pathology. 2024 Jun;56(4):578-579. doi: 10.1016/j.pathol.2023.09.015. Epub 2023 Nov 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Azoles / pharmacology
  • Azoles / therapeutic use
  • Breakthrough Infections / drug therapy
  • Breakthrough Infections / genetics
  • Breakthrough Infections / microbiology
  • Candida albicans* / genetics
  • Candidemia* / drug therapy
  • Candidemia* / microbiology
  • Drug Resistance, Fungal* / genetics
  • Fungal Proteins / genetics
  • Gene Deletion
  • Humans
  • Male
  • Oxidoreductases / genetics

Substances

  • Antifungal Agents
  • Azoles
  • Fungal Proteins
  • sterol delta-5 desaturase
  • Oxidoreductases